Genesem Statistics

Total Valuation

Genesem has a market cap or net worth of KRW 77.08 billion. The enterprise value is 85.76 billion.

Market Cap	77.08B
Enterprise Value	85.76B

Important Dates

The last earnings date was Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Genesem has 8.77 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	8.77M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.36%
Owned by Institutions (%)	0.63%
Float	4.88M

Valuation Ratios

The trailing PE ratio is 9.67.

PE Ratio	9.67
Forward PE	n/a
PS Ratio	1.06
PB Ratio	1.64
P/TBV Ratio	n/a
P/FCF Ratio	8.18
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.07, with an EV/FCF ratio of 9.10.

EV / Earnings	10.75
EV / Sales	1.18
EV / EBITDA	9.07
EV / EBIT	10.45
EV / FCF	9.10

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.45.

Current Ratio	1.41
Quick Ratio	0.84
Debt / Equity	0.45
Debt / EBITDA	2.24
Debt / FCF	2.25
Interest Coverage	9.32

Financial Efficiency

Return on equity (ROE) is 18.12% and return on invested capital (ROIC) is 7.93%.

Return on Equity (ROE)	18.12%
Return on Assets (ROA)	6.20%
Return on Capital (ROIC)	7.93%
Revenue Per Employee	436.72M
Profits Per Employee	48.04M
Employee Count	166
Asset Turnover	0.88
Inventory Turnover	2.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.69%
50-Day Moving Average	8,278.20
200-Day Moving Average	11,355.35
Relative Strength Index (RSI)	47.05
Average Volume (20 Days)	122,312

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genesem had revenue of KRW 72.49 billion and earned 7.98 billion in profits. Earnings per share was 909.45.

Revenue	72.49B
Gross Profit	28.82B
Operating Income	8.21B
Pretax Income	8.18B
Net Income	7.98B
EBITDA	9.46B
EBIT	8.21B
Earnings Per Share (EPS)	909.45

Full Income Statement

Balance Sheet

The company has 12.31 billion in cash and 21.15 billion in debt, giving a net cash position of -8.84 billion or -1,008.19 per share.

Cash & Cash Equivalents	12.31B
Total Debt	21.15B
Net Cash	-8.84B
Net Cash Per Share	-1,008.19
Equity (Book Value)	46.97B
Book Value Per Share	5,373.98
Working Capital	13.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.04 billion and capital expenditures -625.07 million, giving a free cash flow of 9.42 billion.

Operating Cash Flow	10.04B
Capital Expenditures	-625.07M
Free Cash Flow	9.42B
FCF Per Share	1,074.20

Full Cash Flow Statement

Margins

Gross margin is 39.75%, with operating and profit margins of 11.32% and 11.00%.

Gross Margin	39.75%
Operating Margin	11.32%
Pretax Margin	11.28%
Profit Margin	11.00%
EBITDA Margin	13.05%
EBIT Margin	11.32%
FCF Margin	12.99%

Dividends & Yields

Genesem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	10.35%
FCF Yield	12.22%

Dividend Details

Stock Splits

The last stock split was on November 10, 2015. It was a forward split with a ratio of 2.

Last Split Date	Nov 10, 2015
Split Type	Forward
Split Ratio	2

Scores

Genesem has an Altman Z-Score of 3.37.

Altman Z-Score	3.37
Piotroski F-Score	n/a